SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026208
Filing Date
2018-11-01
Accepted
2018-11-01 16:01:33
Documents
46
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gern-10q_20180930.htm 10-Q 1644822
2 EX-10.1 gern-ex101_99.htm EX-10.1 35702
3 EX-10.2 gern-ex102_100.htm EX-10.2 33532
4 EX-31.1 gern-ex311_7.htm EX-31.1 17412
5 EX-31.2 gern-ex312_9.htm EX-31.2 17432
6 EX-32.1 gern-ex321_8.htm EX-32.1 7644
7 EX-32.2 gern-ex322_6.htm EX-32.2 7630
  Complete submission text file 0001564590-18-026208.txt   5787610

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT gern-20180930.xml EX-101.INS 1470861
9 XBRL TAXONOMY EXTENSION SCHEMA gern-20180930.xsd EX-101.SCH 28051
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gern-20180930_cal.xml EX-101.CAL 29237
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gern-20180930_def.xml EX-101.DEF 92093
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20180930_lab.xml EX-101.LAB 237632
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20180930_pre.xml EX-101.PRE 169888
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 181153618
SIC: 2834 Pharmaceutical Preparations